Directions | Contact Us | Sitemap  
 
 
Phone (206) 267-2100 • Fax 206-267-2101 • info@DASeattle.com

 

 

 

Dermatology Research

 

Dedicated to Conducting the Highest Quality of Clinical Research

 

 

Our Current Activities

 

We are dedicated to improving the quality of life for those suffering from skin disorders and diseases

 

If you are interested in learning more about our research program and current study activities, please contact our clinic at (206) 267-2100, or email us at info@DASeattle.com.

 

 

Resource Websites

 

Brief Description Website
Nonprofit organization that is the voice for people affected by psoriasis and psoriatic arthritis www.Psoriasis.org
Use this site to find a wealth of information about clinical research www.CenterWatch.com
Provides information about federally and privately supported clinical research in human volunteers www.ClinicalTrials.gov

 

Psoriasis Research & Treatment

 

Trademark / Brand Website
Enbrel ® www.enbrel.com
Amevive ® www.amevive.com
Raptiva ® www.raptiva.com
Remicade ® www.remicade.com

 

Current Study Activities

 

Dr. Goffe has served as a principal investigator for numerous clinical trials over the years. Our facility is continually active with different types of research studies. Below is a list of the studies that we are currently enrolling for:

  • Genentech Long term use of biologics
  • Observational study on childhood use of Protopic Cream
  • Genentech study treating patients with Raptiva who have not responded to Anti-TNF treatment
  • Amgen open label biopsy study evaluating gene suppression in psoriasis on patients taking Enbrel (pending)
  • Johnson & Johnson phase I study of investigational new drug for Atopic Dermatitis
  • Novartis Phase II for new psoriatic drug
  • Novartis study evaluating Elidel in treating Seborrheic Dermatitis

If you would like to learn more about participation in one of these studies or future investigational studies, please contact us at (206) 267-2100 to speak with our research staff about enrollment, or contact us for more information.

 

 

^ Top